Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > How high can this go Walter $20 maybe. Could be big
View:
Post by RamboOO7 on Apr 18, 2022 3:56pm

How high can this go Walter $20 maybe. Could be big

Any comments ?
Comment by WalterTheDawg on Apr 18, 2022 4:00pm
I have no real thoughts on long term price. Stem cell adoption by the FDA is still in it's infancy but there are a few approved in Canada. I do have near term targets that are over double todays SP based on how the company will be valued after good to great results from their phase 2 clinical trial and they are very conservative. I'll leave the big dreams to big dreamers.
Comment by RamboOO7 on Apr 18, 2022 4:38pm
Stems sells would be awesome. Would save a lot of operations $$$$$
Comment by RamboOO7 on Apr 18, 2022 4:40pm
Volume is picking up.Good sign this can pop high soon.
Comment by fox7mf on Apr 18, 2022 5:04pm
This could go to +$20 a share and could be a target of a successful post phase 2, pre phase 3 buyout for a couple of B's...IMO. Thomas continually mentioned Myokardia's $13.1b usd buyout, who are in a similar space, and who's science may not even be as strong as ours. While that amount may be 'pie in the sky', I'm holding for wtv the buyout may yield. GLTA!!
Comment by RamboOO7 on Apr 18, 2022 5:18pm
Yeah that's my thinking.Could be huge world wide !
Comment by RamboOO7 on Apr 18, 2022 5:55pm
I am interested in adding more shares. I will be watching closely
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities